Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FDG-PET/CT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00725387
What this trial is testing

Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy

Who this might be right for
Neoplasms
Stanford University 214
Not applicableLooking for participantsNCT06450548
What this trial is testing

Dynamic 68Ga-PSMA and 18F-FDG PET/CT Analysis Prior to 177Lu-PSMA

Who this might be right for
Prostate Cancer Metastatic
Centre Henri Becquerel 60
Not applicableStudy completedNCT00282906
What this trial is testing

FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Southern California 257
Not applicableActive Not RecruitingNCT04804371
What this trial is testing

Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
University Health Network, Toronto 40
Not applicableStudy completedNCT03575949
What this trial is testing

Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Malignant Neoplasm in the Spine
M.D. Anderson Cancer Center 14
Not applicableLooking for participantsNCT06017973
What this trial is testing

The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus

Who this might be right for
Status EpilepticusIctal-interictal ContinuumPositron-emission Tomography+2 more
Universitaire Ziekenhuizen KU Leuven 200
Not applicableStudy completedNCT03378193
What this trial is testing

Prognostic Value of 18FDG PET/CT Textural Indices in HNSCC

Who this might be right for
Cancer of Head and Neck
University Hospital, Brest 284
Not applicableStudy completedNCT01986985
What this trial is testing

Comparison of 18F FDG PET/CT TO PET MRI

Who this might be right for
Any Condition With a Clinical Indication for PET/CT Exam
GE Healthcare 58
Not applicableUnknownNCT04519255
What this trial is testing

Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT

Who this might be right for
PET/CTCOVID-19Respiratory Function+1 more
Fifth Affiliated Hospital, Sun Yat-Sen University 60
Not applicableUnknownNCT05056259
What this trial is testing

Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients

Who this might be right for
Endometrial Cancer
Assiut University 42
Not applicableStudy completedNCT05251168
What this trial is testing

PET Guided Bone Marrow Biopsy vs Trephine Bone Marrow Biopsy

Who this might be right for
LymphomaBone Marrow Neoplasm
Post Graduate Institute of Medical Education and Research, Chandigarh 180
Not applicableStudy completedNCT02999490
What this trial is testing

18F-FDG PET/CT in Diagnostic Patients of Disorder of Consciousness

Who this might be right for
Persistent Vegetative State
Guangzhou General Hospital of Guangzhou Military Command 20
Early research (Phase 1)Ended earlyNCT00707213
What this trial is testing

FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients

Who this might be right for
Cancer
University of Utah 19
Post-approval studies (Phase 4)Looking for participantsNCT05428826
What this trial is testing

Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis

Who this might be right for
Idiopathic Retroperitoneal Fibrosis
Assistance Publique - Hôpitaux de Paris 41
Not applicableStudy completedNCT05432947
What this trial is testing

68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 42
Not applicableStudy completedNCT02753569
What this trial is testing

Imaging NSCLC Treatment Response to Immunotherapy

Who this might be right for
Cancer
Institute of Cancer Research, United Kingdom 10
Not applicableStudy completedNCT02792959
What this trial is testing

Evaluation of Response to the Neoadjuvant Chemotherapy for Advanced Ovarian Cancer by Multimodal Functional Imaging

Who this might be right for
Ovarian Cancer
Institut Bergonié 11
Not applicableEnded earlyNCT05513027
What this trial is testing

Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection

Who this might be right for
Cancer
Washington University School of Medicine 11
Not applicableNot Yet RecruitingNCT07523516
What this trial is testing

Diagnostic Performance of 18F-FDG PET/CT in Detecting Distant Metastases in Breast Cancer

Who this might be right for
Breast Cancer (Locally Advanced or Metastatic)
Assiut University 97
Not applicableStudy completedNCT04566185
What this trial is testing

Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Centre Hospitalier Universitaire de Nīmes 14
Next Page